These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26022351)

  • 1. Inhibition of breast cancer cell migration by activation of cAMP signaling.
    Dong H; Claffey KP; Brocke S; Epstein PM
    Breast Cancer Res Treat; 2015 Jul; 152(1):17-28. PubMed ID: 26022351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of phosphodiesterase 7 inhibition by RNA interference on the gene expression and differentiation of human mesenchymal stem cell-derived osteoblasts.
    Pekkinen M; Ahlström MEB; Riehle U; Huttunen MM; Lamberg-Allardt CJE
    Bone; 2008 Jul; 43(1):84-91. PubMed ID: 18420479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PDE8 controls CD4
    Basole CP; Nguyen RK; Lamothe K; Vang A; Clark R; Baillie GS; Epstein PM; Brocke S
    Cell Signal; 2017 Dec; 40():62-72. PubMed ID: 28851628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial cell cyclic nucleotide phosphodiesterases and regulated cell migration: implications in angiogenesis.
    Netherton SJ; Maurice DH
    Mol Pharmacol; 2005 Jan; 67(1):263-72. PubMed ID: 15475573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of PDE8A, a novel human cAMP-specific phosphodiesterase.
    Fisher DA; Smith JF; Pillar JS; St Denis SH; Cheng JB
    Biochem Biophys Res Commun; 1998 May; 246(3):570-7. PubMed ID: 9618252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphodiesterase 8 (PDE8) regulates chemotaxis of activated lymphocytes.
    Dong H; Osmanova V; Epstein PM; Brocke S
    Biochem Biophys Res Commun; 2006 Jun; 345(2):713-9. PubMed ID: 16696947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential Expression and Function of PDE8 and PDE4 in Effector T cells: Implications for PDE8 as a Drug Target in Inflammation.
    Vang AG; Basole C; Dong H; Nguyen RK; Housley W; Guernsey L; Adami AJ; Thrall RS; Clark RB; Epstein PM; Brocke S
    Front Pharmacol; 2016; 7():259. PubMed ID: 27601994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinase A (PKA) pathway is functionally linked to androgen receptor (AR) in the progression of prostate cancer.
    Sarwar M; Sandberg S; Abrahamsson PA; Persson JL
    Urol Oncol; 2014 Jan; 32(1):25.e1-12. PubMed ID: 23410945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour growth inhibition and anti-angiogenic effects using curcumin correspond to combined PDE2 and PDE4 inhibition.
    Abusnina A; Keravis T; Zhou Q; Justiniano H; Lobstein A; Lugnier C
    Thromb Haemost; 2015 Feb; 113(2):319-28. PubMed ID: 25230992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphodiesterase-4 promotes proliferation and angiogenesis of lung cancer by crosstalk with HIF.
    Pullamsetti SS; Banat GA; Schmall A; Szibor M; Pomagruk D; Hänze J; Kolosionek E; Wilhelm J; Braun T; Grimminger F; Seeger W; Schermuly RT; Savai R
    Oncogene; 2013 Feb; 32(9):1121-34. PubMed ID: 22525277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic nucleotide phosphodiesterases (PDEs) in human osteoblastic cells; the effect of PDE inhibition on cAMP accumulation.
    Ahlström M; Pekkinen M; Huttunen M; Lamberg-Allardt C
    Cell Mol Biol Lett; 2005; 10(2):305-19. PubMed ID: 16010295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carvedilol suppresses migration and invasion of malignant breast cells by inactivating Src involving cAMP/PKA and PKCδ signaling pathway.
    Dezong G; Zhongbing M; Qinye F; Zhigang Y
    J Cancer Res Ther; 2014; 10(4):998-1003. PubMed ID: 25579542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial sub-cellular localization of cAMP-specific phosphodiesterase 8A in ovarian follicular cells.
    Lounas A; Vernoux N; Germain M; Tremblay ME; Richard FJ
    Sci Rep; 2019 Aug; 9(1):12493. PubMed ID: 31462694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling of functional phosphodiesterase in mesangial cells using a CRE-SEAP-based reporting system.
    Zhu Y; Yao J; Meng Y; Kasai A; Hiramatsu N; Hayakawa K; Miida T; Takeda M; Okada M; Kitamura M
    Br J Pharmacol; 2006 Jul; 148(6):833-44. PubMed ID: 16751794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human breast cancer cell metastasis is attenuated by lysyl oxidase inhibitors through down-regulation of focal adhesion kinase and the paxillin-signaling pathway.
    Chen LC; Tu SH; Huang CS; Chen CS; Ho CT; Lin HW; Lee CH; Chang HW; Chang CH; Wu CH; Lee WS; Ho YS
    Breast Cancer Res Treat; 2012 Aug; 134(3):989-1004. PubMed ID: 22434522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of cyclic nucleotide phosphodiesterases with cyclic AMP analogs: topology of the catalytic sites and comparison with other cyclic AMP-binding proteins.
    Butt E; Beltman J; Becker DE; Jensen GS; Rybalkin SD; Jastorff B; Beavo JA
    Mol Pharmacol; 1995 Feb; 47(2):340-7. PubMed ID: 7870042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiling human phosphodiesterase genes and splice isoforms.
    Bingham J; Sudarsanam S; Srinivasan S
    Biochem Biophys Res Commun; 2006 Nov; 350(1):25-32. PubMed ID: 16987497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution and function of 3',5'-Cyclic-AMP phosphodiesterases in the human ovary.
    Petersen TS; Kristensen SG; Jeppesen JV; Grøndahl ML; Wissing ML; Macklon KT; Andersen CY
    Mol Cell Endocrinol; 2015 Mar; 403():10-20. PubMed ID: 25578602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic nucleotide phosphodiesterase (PDE) inhibitors: novel therapeutic agents for progressive renal disease.
    Cheng J; Grande JP
    Exp Biol Med (Maywood); 2007 Jan; 232(1):38-51. PubMed ID: 17202584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphodiesterase 4 inhibition synergizes with relaxin signaling to promote decidualization of human endometrial stromal cells.
    Bartsch O; Bartlick B; Ivell R
    J Clin Endocrinol Metab; 2004 Jan; 89(1):324-34. PubMed ID: 14715868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.